9 October 2020
\n \n \n \nA pathway designed to investigate individuals with non-specific but concerning symptoms of cancer wins the BMJ Awards 2020 Cancer Care Team of the Year.
\n \n\n \n \n20 August 2020
\n \n \n \nProf. Anne Kiltie and her team discuss their important work into the effects of radiosensitisation on ageing cancer patients with the CRUK Science Blog.
\n \n\n \n \n22 July 2020
\n \n \n \nUnderstanding the molecular subtype of a cancer is becoming an importance part of the diagnostic process as it helps a doctor better understand a patient\u2019s prognosis, determine the best course of action for treatment and helps researchers devise new, more-efficient, precision therapies.
\n \n\n \n \n8 July 2020
\n \n \n \nProfessor Nicola Sibson has been involved in the CNIO platform to compile a repository for brain metastasis cell lines.
\n \n\n \n \n4 June 2020
\n \n \n \nOne of our scientists, Dr Hannah Bolland, has become a virtual teacher, connecting school students with science.
\n \n\n \n \n23 April 2020
\n \n \n \nMany congratulations to Dr Mark Hill, who has become a Fellow of the Society for Radiological Protection (FSRP).
\n \n\n \n \n26 March 2020
\n \n \n \nUK National Cancer Imaging Translational Accelerator (NCITA) establishes infrastructure for validation and adoption of cancer imaging biomarkers as decision-making tools in clinical trials and NHS practice. Researchers and medical experts from nine world-leading medical imaging centres across the UK come together to form an integrated infrastructure for standardising and validating cancer imaging biomarkers for clinical use.
\n \n\n \n \n9 March 2020
\n \n \n \nGroup of Professor Kristijan Ramadan has published an original scientific article in Nature Communications today. The article has the first report of a new autophagy receptor TEX264, which may be involved in tumours developing drug resistance.
\n \n\n \n \n6 February 2020
\n \n \n \nCongratulations to Prof Kristijan Ramadan who has been awarded a three year research grant from Breast Cancer Now. The grant will support Dr. Abhay Narayan Singh who will explore new ways to use chemotherapy in order to improve the outcomes for women with breast cancer.
\n \n\n \n \n4 February 2020
\n \n \n \nTuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/).\r\n\r\nLed by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.
\n \n\n \n \n4 November 2019
\n \n \n \nThe NIHR has invested \u00a334 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).
\n \n\n \n \n15 October 2019
\n \n \n \nKristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
\n \n\n \n \n20 September 2019
\n \n \n \nThe Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
\n \n\n \n \n17 September 2019
\n \n \n \nOn 14 September, the Old Road Campus joined the 2019 Oxford Open Doors event and welcomed the public into our workplace.
\n \n\n \n \n8 August 2019
\n \n \n \nThe new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
\n \n\n \n \n25 July 2019
\n \n \n \nMadalena Tarsounas' group have recently published two new papers in EMBO Molecular Medicine and Nature Communications.
\n \n\n \n \n18 July 2019
\n \n \n \nKristijan Ramadan's group have published a new paper which shows how cells keep the DNA replication machinery moving when faced with blockers.
\n \n\n \n \n25 March 2019
\n \n \n \nResearch by the DNA Damage & Disease research group has for the first time observed molecular fibres that may hold together sections of broken DNA in mitosis.
\n \n\n \n \n12 February 2019
\n \n \n \nResearchers in Oxford have found that an individual\u2019s immune system \u2013 and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.
\n \n\n \n \n7 February 2019
\n \n \n \nGenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer.
\n \n\n \n \n